Literature DB >> 10608807

Extensive post-translational modification, including serine to D-alanine conversion, in the two-component lantibiotic, lacticin 3147.

M P Ryan1, R W Jack, M Josten, H G Sahl, G Jung, R P Ross, C Hill.   

Abstract

Lacticin 3147 is a two-component bacteriocin produced by Lactococcus lactis subspecies lactis DPC3147. In order to further characterize the biochemical nature of the bacteriocin, both peptides were isolated which together are responsible for the antimicrobial activity. The first, LtnA1, is a 3,322 Da 30-amino acid peptide and the second component, LtnA2, is a 29-amino acid peptide with a mass of 2,847 Da. Conventional amino acid analysis revealed that both peptides contain the thioether amino acid, lanthionine, as well as an excess of alanine to that predicted from the genetic sequence of the peptides. Chiral phase gas chromatography coupled with mass spectrometry of amino acid composition indicated that both LtnA1 and LtnA2 contain D-alanine residues and amino acid sequence analysis of LtnA1 confirmed that the D-alanine results from post-translational modification of a serine residue in the primary translation product. Taken together, these results demonstrate that lacticin 3147 is a novel, two-component, D-alanine containing lantibiotic that undergoes extensive post-translational modification which may account for its potent antimicrobial activity against a wide range of Gram-positive bacteria.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10608807     DOI: 10.1074/jbc.274.53.37544

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Lantibiotic biosynthesis: interactions between prelacticin 481 and its putative modification enzyme, LctM.

Authors:  P Uguen; J P Le Pennec; A Dufour
Journal:  J Bacteriol       Date:  2000-09       Impact factor: 3.490

2.  Generation of food-grade lactococcal starters which produce the lantibiotics lacticin 3147 and lacticin 481.

Authors:  Lisa O'Sullivan; Maire P Ryan; R Paul Ross; Colin Hill
Journal:  Appl Environ Microbiol       Date:  2003-06       Impact factor: 4.792

3.  Sequential actions of the two component peptides of the lantibiotic lacticin 3147 explain its antimicrobial activity at nanomolar concentrations.

Authors:  Sheila M Morgan; Paula M O'connor; Paul D Cotter; R Paul Ross; Colin Hill
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

4.  Overproduction of wild-type and bioengineered derivatives of the lantibiotic lacticin 3147.

Authors:  Paul D Cotter; Lorraine A Draper; Elaine M Lawton; Olivia McAuliffe; Colin Hill; R Paul Ross
Journal:  Appl Environ Microbiol       Date:  2006-06       Impact factor: 4.792

Review 5.  Bacteriocin diversity in Streptococcus and Enterococcus.

Authors:  Ingolf F Nes; Dzung B Diep; Helge Holo
Journal:  J Bacteriol       Date:  2006-11-10       Impact factor: 3.490

6.  Investigating the importance of charged residues in lantibiotics.

Authors:  Srinivas Suda; Colin Hill; Paul D Cotter; R Paul Ross
Journal:  Bioeng Bugs       Date:  2010 Sep-Oct

Review 7.  Mechanistic Understanding of Lanthipeptide Biosynthetic Enzymes.

Authors:  Lindsay M Repka; Jonathan R Chekan; Satish K Nair; Wilfred A van der Donk
Journal:  Chem Rev       Date:  2017-01-30       Impact factor: 60.622

8.  Trypsin mediates growth phase-dependent transcriptional tegulation of genes involved in biosynthesis of ruminococcin A, a lantibiotic produced by a Ruminococcus gnavus strain from a human intestinal microbiota.

Authors:  Ana Gomez; Monique Ladiré; Françoise Marcille; Michel Fons
Journal:  J Bacteriol       Date:  2002-01       Impact factor: 3.490

9.  Dissecting structural and functional diversity of the lantibiotic mersacidin.

Authors:  Antony N Appleyard; Shaila Choi; Daniel M Read; Ann Lightfoot; Steven Boakes; Anja Hoffmann; Ian Chopra; Gabriele Bierbaum; Brian A M Rudd; Michael J Dawson; Jesus Cortes
Journal:  Chem Biol       Date:  2009-05-29

10.  Insights into the mode of action of the two-peptide lantibiotic haloduracin.

Authors:  Trent J Oman; Wilfred A van der Donk
Journal:  ACS Chem Biol       Date:  2009-10-16       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.